Anti-biofilm strategies and the need for innovations in wound care

Recent Patents on Anti-Infective Drug Discovery

Volumn 5, Issue 1, 2010, Pages 10-17

  Ammons, Mary C B ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

Bacterial biofilm; Therapy; Wound care

Indexed keywords

ACETYLGLUCOSAMINIDASE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BIOCIDE; BISMUTH DERIVATIVE; CADEXOMER IODINE; DISPERSIN B; EDETIC ACID; GALLIUM; IODINE; LACTOFERRIN; POVIDONE IODINE; QUATERNARY AMMONIUM DERIVATIVE; SILVER; UNCLASSIFIED DRUG; XYLITOL;

AGING; ARTICLE; BACTERIOPHAGE; BATTLE INJURY; BIOFILM; CHRONIC WOUND; DEBRIDEMENT; DRUG SENSITIVITY; HONEY; HUMAN; NONHUMAN; OBESITY; PRIORITY JOURNAL; QUORUM SENSING; STANDARD; WOUND CARE; WOUND INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BANDAGES; BIOFILMS; CHRONIC DISEASE; DEBRIDEMENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; INFECTION CONTROL; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; TREATMENT OUTCOME; ULCER; WOUND HEALING;

EID: 77953793696     PISSN: 1574891X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489110790112581     Document Type: Article

References (133)

1. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16(1): 37-44.
2. Economic costs of diabetes in the U.S. in 2007. Diabetes care 2008; 31(3): 596-615.
3. McGuckin M, Goldman R, Bolton L, Salcido R. The clinical relevance of microbiology in acute and chronic wounds. Adv Skin Wound Care 2003; 16(1): 12-23;[quiz 4-5].
4. Bjarnsholt T, Kirketerp-Moller K, Jensen PO, et al. Why chronic wounds will not heal: A novel hypothesis. Wound Repair Regen 2008; 16(1): 2-10.
5. Konturek PC, Brzozowski T, Konturek SJ, Kwiecien S, Dembinski A, Hahn EG. Influence of bacterial lipopolysaccharide on healing of chronic experimental ulcer in rat. Scand J Gastroenterol 2001; 36(12): 1239-1247.
6. Power C, Wang JH, Sookhai S, Street JT, Redmond HP. Bacterial wall products induce downregulation of vascular endothelial growth factor receptors on endothelial cells via a CD14-dependent mechanism: Implications for surgical wound healing. J Surg Res 2001; 101(2): 138-145.
7. White RJ, Cutting KF. Critical colonization--the concept under scrutiny. Ostom/Wound Manage 2006; 52(11): 50-56.
8. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999; 21; 284 (5418): 1318-1322.
9. Costerton JW, Stewart PS. Battling biofilms. Sci Am 200; 285(1): 74-81.
10. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15(2): 167-193.
11. Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Ann Rev Microbiol 2003; 57: 677-701.
12. Davis SC, Ricotti C, Cazzaniga A, Welsh E, Eaglstein WH, Mertz PM. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2008; 16(1): 23-29.
13. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 2003; 29(6): 631-635.
14. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen 2008; 16(1): 37-44.
15. Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2003; 2(2): 114-122.
16. Aronson NE, Sanders JW, Moran KA. In harm's way: Infections in deployed American military forces. Clin Infect Dis 2006; 43(8): 1045-1051.
17. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005; 13(1): 34-40.
18. Davey ME, O'Toole GA. Microbial biofilms: From ecology to molecular genetics. Microbiol Mol Biol Rev 2000; 64(4): 847-867.
19. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000; 46(6): S47-52.
20. Sternberg C, Christensen BB, Johansen T, et al. Distribution of bacterial growth activity in flow-chamber biofilms. Appl Environ Microbiol 1999; 65(9): 4108-4117.
21. Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res 1994; 8(2): 263-271.
22. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS. Bacterial coaggregation: An integral process in the development of multi-species biofilms. Trends Microbiol 2003; 11(2): 94-100.
23. Oggioni MR, Trappetti C, Kadioglu A, et al. Switch from planktonic to sessile life: A major event in pneumococcal pathogenesis. Mol Microbiol 2006; 61(5): 1196-1210.
24. Burmolle M, Webb JS, Rao D, Hansen LH, Sorensen SJ, Kjelleberg S. Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms. Appl Environ Microbiol 2006; 72(6): 3916-3923.
25. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 2004; 186(24): 8172-8180.
26. Cookson B. Clinical significance of emergence of bacterial antimicrobial resistance in the hospital environment. J Appl Microbiol 2005; 99(5): 989-996.
27. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264(5157): 375-382.
28. Rhoads DD, Wolcott RD, Percival SL. Biofilms in wounds: Management strategies. J Wound Care 2008; 17(11): 502-508.
29. Wilson JR, Mills JG, Prather ID, Dimitrijevich SD. A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 2005; 18(7): 373-378.
30. Mertz PM, Eaglstein WH. The effect of a semiocclusive dressing on the microbial population in superficial wounds. Arch Surg 1984; 119(3): 287-289.
31. White RJ, Cutting K, Kingsley A. Topical antimicrobials in the control of wound bioburden. Ostomy/Wound Manage 2006; 52(8): 26-58.
32. Percival SL, Bowler PG, Dolman J. Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 2007; 4(2): 186-191.
33. Newman GR, Walker M, Hobot JA, Bowler PG. Visualisation of bacterial sequestration and bactericidal activity within hydrating Hydrofiber wound dressings. Biomaterials 2006; 27(7): 1129-1139.
34. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990; 16(3): 211-215.
35. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127(4): 275-280.
36. Wolcott RD, Rhoads DD. A study of biofilm-based wound management in subjects with critical limb ischaemia. J Wound Care 2008; 17(4): 145-148, 50-52, 54-55.
37. Schultz GS, Barillo DJ, Mozingo DW, Chin GA. Wound bed preparation and a brief history of time. Int Wound J 2004; 1(1): 19-32.
38. Gray M. Is larval (maggot) debridement effective for removal of necrotic tissue from chronic wounds? J Wound Ostomy Continence Nurs 2008; 35(4): 378-384.
39. Shimko, D.A., Olson, Jr., S.W., Nycz, J.H.: US20070135706 (2007).
40. Schaden, W., Schultheiss, R., Warlick, J.: US20070239073 (2007).
41. Babaev, E.: US20080183109 (2008).
42. Ensing GT, Roeder BL, Nelson JL, et al. Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements in vivo. J Appl Microbiol 2005; 99(3): 443-448.
43. Ensing GT, Neut D, van Horn JR, van der Mei HC, Busscher HJ. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: an in vitro study with clinical strains. J Antimicrob Chemother 2006; 58(6): 1287-1290.
44. Jones SA, Bowler PG, Walker M, Parsons D. Controlling wound bioburden with a novel silver-containing Hydrofiber dressing. Wound Repair Regen 2004; 12(3): 288-294.
45. Percival SL, Bowler P, Woods EJ. Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 2008; 16(1): 52-57.
46. Bjarnsholt T, Kirketerp-Moller K, Kristiansen S, et al. Silver against Pseudomonas aeruginosa biofilms. APMIS 2007; 115(8): 921-928.
47. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994; 31: 351-370.
48. Lansdown AB, Sampson B, Laupattarakasem P, Vuttivirojana A. Silver aids healing in the sterile skin wound: Experimental studies in the laboratory rat. Br J Dermatol 1997; 137(5): 728-735.
49. Gillis, S.H., Schechter, P., Stiles, J.A.R.: US20040131698 (2004).
50. Poon VK, Burd A. in vitro Cytotoxity of silver: Implication for clinical wound care. Burns 2004; 30(2): 140-147.
51. Kramer SA. Effect of povidone-iodine on wound healing: A review. J Vasc Nurs 1999; 17(1): 17-23.
52. Presterl E, Suchomel M, Eder M, et al. Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2007; 60(2): 417-420.
53. Niedner R. Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology 1997; 195 (Suppl 2): 89-92.
54. Budney, J.A., Budny, M.J.: US20020037260 (2002).
55. Komori, S., Muramatsu, T.: US4844898 (1989).
56. Skog E, Arnesjo B, Troeng T, et al. A randomized trial comparing cadexomer iodine and standard treatment in the out-patient management of chronic venous ulcers. Br J Dermatol 1983; 109(1): 77-83.
57. Akiyama H, Oono T, Saito M, Iwatsuki K. Assessment of cadexomer iodine against Staphylococcus aureus biofilm in vivo and in vitro using confocal laser scanning microscopy. J Dermatol 2004; 31(7): 529-534.
58. Chitambar CR, Narasimhan J. Targeting iron-dependent DNA synthesis with gallium and transferrin-gallium. Pathobiology 1991; 59(1): 3-10.
59. Warrell RP Jr, Bockman RS, Coonley CJ, Isaacs M, Staszewski H. Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia. J Clin Invest 1984; 73(5): 1487-1490.
60. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 2007; 117(4): 877-888.
61. Bucalo, L.R., Schwendner, S., Wirtz, U.F., Sreedharan, S.: US20070231406 (2007).
62. Perl, D.P., Moalem, S.: US20080241275 (2008).
63. Britigan, B.E., Singh, P.K.: US20060018945 (2006).
64. Bernstein LR, Tanner T, Godfrey C, Noll B. Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability. Met Based Drugs 2000; 7(1): 33-47.
65. Gray GW, Wilkinson SG. The effect of ethylenediaminetetra-acetic acid on the cell walls of some gram-negative bacteria. J Gen Microbiol 1965; 39(3): 385-399.
66. Aaseth J. Recent advance in the therapy of metal poisonings with chelating agents. Hum Toxicol 1983; 2(2): 257-272.
67. Ernst E. Chelation therapy for coronary heart disease: An overview of all clinical investigations. Am Heart J 2000; 140(1): 139-141.
68. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP. Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: Relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother 1988; 32(11): 1627-1631.
69. Kite P, Eastwood K, Sugden S, Percival SL. Use of in vivo generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 2004; 42(7): 3073-3076.
70. Percival SL, Bowler PG, Russell D. Bacterial resistance to silver in wound care. J Hosp Infect 2005; 60(1): 1-7.
71. Martineau L, Dosch HM. Biofilm reduction by a new burn gel that targets nociception. J Appl Microbiol 2007; 103(2): 297-304.
72. Kite, P., Hatton, D.: US20040110841 (2004).
73. Stoiber T, Bonacker D, Bohm KJ, et al. Disturbed microtubule function and induction of micronuclei by chelate complexes of mercury(II). Mutat Res 2004; 563(2): 97-106.
74. Leung KP, Crowe TD, Abercrombie JJ, et al. Control of oral biofilm formation by an antimicrobial decapeptide. J Dental Res 2005; 84(12): 1172-1177.
75. Domenico P, Baldassarri L, Schoch PE, Kaehler K, Sasatsu M, Cunha BA. Activities of bismuth thiols against Staphylococci and Staphylococcal biofilms. Antimicrob Agents Chemother 2001; 45(5): 1417-1421.
76. Bates, B.L., Hiles, M.C., Johnson, C.E.: US20080181950 (2008).
77. Alandejani T, Marsan J, Ferris W, Slinger R, Chan F. Effectiveness of honey on Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Otolaryngol Head Neck Surg 2009; 141(1): 114-118.
78. Tonks A, Cooper RA, Price AJ, Molan PC, Jones KP. Stimulation of TNF-alpha release in monocytes by honey. Cytokine 2001; 14(4): 240-242.
79. Tonks AJ, Cooper RA, Jones KP, Blair S, Parton J, Tonks A. Honey stimulates inflammatory cytokine production from monocytes. Cytokine 2003; 21(5): 242-247.
80. Molan PC. The evidence supporting the use of honey as a wound dressing. Int J Low Extrem Wounds 2006; 5(1): 40-54.
81. Molan, P.C.: US20056956144 (2005).
82. Valenti P, Berlutti F, Conte MP, Longhi C, Seganti L. Lactoferrin functions: Current status and perspectives. J Clin Gastroenterol 2004; 38(Suppl 6): S127-129.
83. Brandenburg K, Jurgens G, Muller M, Fukuoka S, Koch MH. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol Chem 2001; 382(8): 1215-1225.
84. Ammons MC, Ward LS, Fisher ST, Wolcott RD, James GA. in vitro Susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int J Antimicrob Agents 2009; 33(3): 230-236.
85. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417(6888): 552-555.
86. Weinberg ED. Human lactoferrin: A novel therapeutic with broad spectrum potential. J Pharm Pharmacol 2001; 53(10): 1303-1310.
87. Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother 2009; 53(8): 3308-3316.
88. O'May CY, Sanderson K, Roddam LF, Kirov SM, Reid DW. Ironbinding compounds impair Pseudomonas aeruginosa biofilm formation, especially under anaerobic conditions. J Med Microbiol 2009; 58(Pt 6): 765-773.
89. Leitch EC, Willcox MD. Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol 1999; 48(9): 867-871.
90. Psaltis AJ, Wormald PJ, Ha KR, Tan LW. Reduced levels of Lactoferrin in biofilm-associated chronic rhinosinusitis. Laryngoscope 2008; 118(5): 895-901.
91. Wolcott, R.: US20070116750 (2007).
92. Cadee, J.A., Tips, P.D., Van Someren, G.D.: US20080318834 (2008).
93. Granstrom TB, Izumori K, Leisola M. A rare sugar xylitol. Part II: Biotechnological production and future applications of xylitol. Appl Microbiol Biotechnol 2007; 74(2): 273-276.
94. Burt BA. The use of sorbitol and xylitol-sweetened chewing gum in caries control. J Am Dent Assoc 2006; 137(2): 190-196.
95. Badet C, Furiga A, Thebaud N. Effect of xylitol on an in vitro model of oral biofilm. Oral Health Prev Dent 2008; 6(4): 337-341.
96. Shemesh M, Tam A, Feldman M, Steinberg D. Differential expression profiles of Streptococcus mutans ftf, gtf and vicR genes in the presence of dietary carbohydrates at early and late exponential growth phases. Carbohydr Res 2006; 341(12): 2090-2097.
97. Yatka, R.J.: US5536511 (1996).
98. Uhari, M.K., Kontiokari, T.T.: US5719196 (1998).
99. Jones, A.H.: US20016258372 (2001).
100. Katsuyama M, Ichikawa H, Ogawa S, Ikezawa Z. A novel method to control the balance of skin microflora. Part 1. Attack on biofilm of Staphylococcus aureus without antibiotics. J Dermatol Sci 2005; 38(3): 197-205.
101. Katsuyama M, Kobayashi Y, Ichikawa H, et al. A novel method to control the balance of skin microflora Part 2. A study to assess the effect of a cream containing farnesol and xylitol on atopic dry skin. J Dermatol Sci 2005; 38(3): 207-213.
102. Ramasubbu N, Thomas LM, Ragunath C, Kaplan JB. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol 2005; 349(3): 475-486.
103. Chaignon P, Sadovskaya I, Ragunah C, Ramasubbu N, Kaplan JB, Jabbouri S. Susceptibility of Staphylococcal biofilms to enzymatic treatments depends on their chemical composition. App Microbiol Biotechnol 2007; 75(1): 125-132.
104. Izano EA, Sadovskaya I, Vinogradov E, et al. Poly-N-acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniae. Microb Pathog 2007; 43(1): 1-9.
105. Izano EA, Sadovskaya I, Wang H, et al. Poly-N-acetylglucosamine mediates biofilm formation and detergent resistance in Aggregatibacter actinomycetemcomitans. Microb Pathog 2008; 44(1): 52-60.
106. Itoh Y, Wang X, Hinnebusch BJ, Preston JF 3rd, Romeo T. Depolymerization of beta-1, 6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 2005; 187(1): 382-387.
107. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dental Res 2007; 86(7): 618-622.
108. Kaplan JB, Fine DH. Biofilm dispersal of Neisseria subflava and other phylogenetically diverse oral bacteria. Appl Environ Microbiol 2002; 68(10): 4943-4950.
109. Kaplan JB, Meyenhofer MF, Fine DH. Biofilm growth and detachment of Actinobacillus actinomycetemcomitans. J Bacteriol 2003; 185(4): 1399-1404.
110. Kaplan JB, Ragunath C, Ramasubbu N, Fine DH. Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous beta-hexosaminidase activity. J Bacteriol 2003; 185(16): 4693-4698.
111. Kaplan JB, Ragunath C, Velliyagounder K, Fine DH, Ramasubbu N. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2004; 48(7): 2633-2636.
112. Kaplan, J.B.: US20077294497 (2007).
113. O'Flaherty S, Ross RP, Coffey A. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 2009; 33(4): 801-819.
114. Abedon ST. Phage evolution and ecology. Adv Appl Microbiol 2009; 67: 1-45.
115. Smith HW, Huggins MB. Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics. J Gen Microbiol 1982; 128(2): 307-318.
116. Barrow P, Lovell M, Berchieri A Jr. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Immunol 1998; 5(3): 294-298.
117. Hughes KA, Sutherland IW, Jones MV. Biofilm susceptibility to bacteriophage attack: The role of phage-borne polysaccharide depolymerase. Microbiol 1998; 144 (Pt 11): 3039-3047.
118. Curtin, J.J., Donlan, R.M.: US20090191254 (2009).
119. Hentzer M, Wu H, Andersen JB, et al. Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. EMBO J 2003; 22(15): 3803-3815.
120. Hentzer M, Eberl L, Nielsen J, Givskov M. Quorum sensing: A novel target for the treatment of biofilm infections. BioDrugs 2003; 17(4): 241-250.
121. Ammendola, A., Aulinger-Fuchs, K., Gotschlich, A., Lang, M., Saeb, W., Sinks, U., Wuzik, A.: EP1475092 (2004).
122. Despeyroux, P., Frehel, D., Schoentjes, B., Van Dorsselaer, V.: US20060052426 (2006).
123. Federle MJ, Bassler BL. Interspecies communication in bacteria. J Clin Investig 2003; 112(9): 1291-1299.
124. Blackwell, H.E., Geske, G.D., O'Neill, J.C.: US20080312319 (2008).
125. Gonzalez JE, Keshavan ND. Messing with bacterial quorum sensing. Microbiol Mol Biol Rev 2006; 70(4): 859-875.
126. Hentzer M, Riedel K, Rasmussen TB, et al. Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. Microbiology 2002; 148(Pt 1): 87-102.
127. Baveja JK, Willcox MD, Hume EB, Kumar N, Odell R, Poole-Warren LA. Furanones as potential anti-bacterial coatings on biomaterials. Biomaterials 2004; 25(20): 5003-5012.
128. Bassler, B.L., Dammel, C., Schauder, S., Shokat, K., Stein, J., Surette, M.G.: US20036559176 (2003).
129. Yun HC, Murray CK, Roop SA, Hospenthal DR, Gourdine E, Dooley DP. Bacteria recovered from patients admitted to a deployed U.S. military hospital in Baghdad, Iraq. Mil Med 2006; 171(9): 821-825.
130. Petersen K, Riddle MS, Danko JR, et al. Trauma-related infections in battlefield casualties from Iraq. Ann Surg 2007; 245(5): 803-811.
131. Trahan L, Mouton C. Selection for Streptococcus mutans with an altered xylitol transport capacity in chronic xylitol consumers. J Dental Res 1987; 66(5): 982-988.
132. Trahan L, Soderling E, Drean MF, Chevrier MC, Isokangas P. Effect of xylitol consumption on the plaque-saliva distribution of mutans Streptococci and the occurrence and long-term survival of xylitol-resistant strains. J Dental Res 1992; 71(11): 1785-1791.
133. Vogel L, Geluk F, Jansen H, Dankert J, van Alphen L. Human lactoferrin receptor activity in non-encapsulated Haemophilus influenzae. FEMS Microbiol Lett 1997; 156(1): 165-170.